G
Greg Higgins
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
Sep 17, 2026
Improving Patient Outcomes: The AI Opportunity in Commercial Pharma
16:37
So do you think that could help us bridge that gap? Or is the regulation going to slow that process down as we need deterministic, provable systems?
G
16:48Greg HigginsGUEST
Where do you think it'll go? This falls under my governance and guardrails category and why projects at all.
G
16:55Greg HigginsGUEST
And absolutely, the algorithms that are used, the LLMs, the models that are used to power the AI in all its processes and guises are logical.
G
17:07Greg HigginsGUEST
The biggest challenge is the business process re-engineering that needs to happen to build that foundation layer.
G
17:15Greg HigginsGUEST
The data quality that we're feeding into a system is going to determine the outputs and the quality of those outputs.
G
17:22Greg HigginsGUEST
One of the key things alongside the business process re-engineering is the outcomes that we want the AI to do.

